ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
April 02, 2024 01:30 ET
|
ONWARD Medical NV
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System.
ONWARD® Medical Lève avec Succès 20 millions d'euros dans le cadre d'une Augmentation de Capital par le biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et d'une Offre au Public en France
March 20, 2024 22:03 ET
|
ONWARD Medical NV
NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT...
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France
March 20, 2024 22:03 ET
|
ONWARD Medical NV
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option
March 20, 2024 13:29 ET
|
ONWARD Medical NV
EINDHOVEN, the Netherlands, March 20, 2024 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER...
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
March 15, 2024 02:30 ET
|
ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, March 15, 2024 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
March 15, 2024 02:30 ET
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 15 mars 2024 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
March 15, 2024 02:30 ET
|
ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, March 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
March 15, 2024 02:30 ET
|
ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company expects to commercialize its ARC-EX®...
ONWARD ontvangt nieuwe FDA Breakthrough Device Designations voor blaascontrole, vermindering van spasticiteit en bloeddrukregeling bij dwarslaesiepatiënten
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), ONWARD Medical N.V. (Euronext: ONWD), het medische...
ONWARD Receives New FDA Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation after Spinal Cord Injury
February 23, 2023 01:30 ET
|
ONWARD Medical
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative...